A 64-year-old woman presented with worsening vision 4 weeks after a belantamab mafodotin, 2.5 mg/kg, infusion for multiple myeloma. Manifest refraction revealed a bilateral +5-diopter hyperopic shift. Slitlamp microscopy demonstrated peripheral corneal epithelial cystlike changes, previously described with belantamab mafodotin and other chemotherapeutic agents (Figure, A).1- 5 Anterior-segment optical coherence tomography highlighted the cysts as small hyperreflective opacities (Figure, B). Pentacam (Oculus) anterior float maps showed a configuration similar to that seen after myopic laser ablation with central corneal flattening (Figure, B, left inset). Scheimpflug tomography pachymetry and corneal epithelial thickness maps (Figure, B, middle, right inset) revealed this was attributable to relative peripheral corneal epithelial thickening. The belantamab mafodotin infusions were discontinued, leading to normalization of her refractive error and resolution of her microcystic keratopathy within 4 and 6 weeks, respectively. Reduced dosage infusions (1.9 mg/kg) resumed with less dense microcyst recurrence. Rigid gas permeable lenses improved her vision to baseline.
Sign in to take quiz and track your certificates
JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC
CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.
Corresponding Author Address: Gerami D. Seitzman, MD, F. I. Proctor Foundation, University of California, San Francisco, 490 Illinois St, 2nd Floor, San Francisco, CA 94158 (firstname.lastname@example.org).
Conflict of Interest Disclosures: Dr Seitzman reported receiving consultant fees from Dompe outside the submitted work. No other disclosures were reported.
Additional Contributions: We thank the patient for granting permission to publish this information.
You currently have no searches saved.
You currently have no courses saved.